Registration No. 333-158542

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM T-1

STATEMENT OF ELIGIBILITY UNDER
THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE

þ Check if an Application to Determine Eligibility of
a Trustee Pursuant to Section 305(b)(2)

U.S. BANK NATIONAL ASSOCIATION

(Exact name of Trustee as specified in its charter)

31-0841368
I.R.S. Employer Identification No.

800 Nicollet Mall Minneapolis, Minnesota		55402
(Address of principal executive offices)		(Zip code)

Thomas E. Tabor
U.S. Bank Trust National Association
100 Wall Street, Suite 1600
New York, New York 10005
Telephone (212) 361-6184
(Name, address and telephone number of agent for service)

INVERNESS MEDICAL INNOVATIONS, INC.
(Exact name of Obligor as specified in its charter)
(See table of additional obligors on following page)

Delaware		04-3565120
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

51 Sawyer Road, Suite 200 Waltham, Massachusetts		02453
(Address of principal executive offices)		(Zip code)

Senior Subordinated Notes Due 2016
(Title of the Indenture Securities)

 

 

TABLE OF ADDITIONAL OBLIGORS

The following direct and indirect wholly owned domestic subsidiaries of Inverness Medical Innovations, Inc. are expected to guarantee the debt securities issued pursuant to the Indenture. The address, including zip code, and telephone number, including area code, of each of the co-obligors is 51 Sawyer Road, Suite 200, Waltham, Massachusetts, 02453, (781) 647-3900:

		State or Other
		Jurisdiction of		I.R.S. Employer
Exact Name of Additional Obligor		Incorporation or		Identification
as Specified in its Charter		Organization		Number
Advantage Diagnostics Corporation		Delaware		20-1247157
Alere LLC		Delaware		26-2564744
Alere Healthcare of Illinois, Inc.		Georgia		58-2068880
Alere Health Improvement Company		Delaware		23-2776413
Alere Health Systems, Inc.		Delaware		22-3493126
Alere Medical, Inc.		California		94-3238845
Alere Wellology, Inc.		Delaware		54-1776557
Alere Women’s and Children’s Health, LLC		Delaware		58-2205984
Ameditech Inc.		California		33-0859551
Applied Biotech, Inc.		California		33-0447325
Binax, Inc.		Delaware		20-2507302
Biosite Incorporated		Delaware		33-0288606
Cholestech Corporation		Delaware		94-3065493
First Check Diagnostics Corp.		Delaware		20-8329751
First Check Ecom, Inc.		Massachusetts		33-1026518
Forefront Diagnostics, Inc.		California		33-0733551
HemoSense, Inc.		Delaware		77-0452938
IM US Holdings, LLC		Delaware		26-0349667
Innovacon, Inc.		Delaware		20-1100264
Innovations Research, LLC		Delaware		20-0653511
Innovative Mobility, LLC		Florida		20-0351538
Instant Technologies, Inc.		Virginia		54-1837621
Inverness Medical, LLC		Delaware		26-0392649
Inverness Medical — Biostar Inc.		Delaware		91-1929582
Inverness Medical Innovations North America, Inc.		Delaware		26-1444559
Inverness Medical International Holding Corp.		Delaware		80-0077873
Inverness Medical International Holding Corp. II		Delaware		20-0963463
Ischemia Technologies, Inc.		Delaware		84-1489537
IVC Industries, Inc.		Delaware		22-1567481
Matritech, Inc.		Delaware		26-1436477
Ostex International, Inc.		Washington		91-1450247
Quality Assured Services, Inc.		Florida		59-3437644
Redwood Toxicology Laboratory, Inc.		California		68-0332937
RTL Holdings, Inc.		Delaware		20-4371685
Selfcare Technology, Inc.		Delaware		04-3383533
Wampole Laboratories, LLC		Delaware		37-1485678

FORM T-1

Item 1.		GENERAL INFORMATION. Furnish the following information as to the Trustee.

	a)		Name and address of each examining or supervising authority to which it is subject.
			Comptroller of the Currency — United States Department of the Treasury Washington, D.C. 20219
	b)		Whether it is authorized to exercise corporate trust powers.
			Yes

Item 2.		AFFILIATIONS WITH OBLIGOR. If the obligor is an affiliate of the Trustee, describe each such affiliation.

                         None

Items 3-15		Items 3-15 are not applicable, because to the best of the Trustee’s knowledge, the obligor is not in default under any Indenture for which the Trustee acts as Trustee.

Item 16.		LIST OF EXHIBITS: List below all exhibits filed as a part of this statement of eligibility and qualification.

	1.		A copy of the Articles of Association of the Trustee.*
	2.		A copy of the certificate of authority of the Trustee to commence business.*
	3.		A copy of the certificate of authority of the Trustee to exercise corporate trust powers.*
	4.		A copy of the existing bylaws of the Trustee.**
	5.		A copy of each Indenture referred to in Item 4. Not applicable.
	6.		The consent of the Trustee required by Section 321(b) of the Trust Indenture Act of 1939, attached as Exhibit 6.
	7.		Report of Condition of the Trustee as of December 31, 2008 published pursuant to law or the requirements of its supervising or examining authority, attached as Exhibit 7.
	8.		Not applicable.
	9.		Not applicable.

SIGNATURE

     Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the Trustee, U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility and qualification to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of New York, State of New York on the 4^th of May, 2009.